SCHEMBL114135

SCHEMBL114135

CCOc1ncc(-c2ccccc2N2CCN(C(C=O)n3nc(C)cc3C)CC2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 7/20 0.41
KCNH2 Q12809 2/20 0.41
TNF P01375 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALPL P05186 1/20 0.32
GLA P06280 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
ESR2 Q92731 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
HTR1A P08908 3/20 0.32
HTR7 P34969 3/20 0.32
TNK2 Q07912 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.31
KDM4E B2RXH2 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL114268 0.91 CXCR3 (0.40) CXCR3KCNH2MEN1KMT2AMAPT
SCHEMBL114563 0.89 CXCR3 (0.42) CXCR3KCNH2MEN1KMT2APOLB
SCHEMBL115477 0.89 CXCR3 (0.42) CXCR3KCNH2POLBMAPTHTR1A
SCHEMBL113540 0.88 CXCR3 (0.40) CXCR3KCNH2ALDH1A1MEN1KMT2A
SCHEMBL115833 0.87 CXCR3 (0.41) CXCR3KCNH2POLB
SCHEMBL115507 0.86 CXCR3 (0.40) CXCR3KCNH2ALDH1A1MAPTTNK2
SCHEMBL113252 0.86 CXCR3 (0.41) CXCR3KCNH2MAPTHTR7TNK2
SCHEMBL113125 0.85 CXCR3 (0.40) CXCR3KCNH2ALDH1A1MAPTHTT
SCHEMBL113545 0.85 CXCR3 (0.42) CXCR3KCNH2MAPTHTR7
SCHEMBL113986 0.85 CXCR3 (0.40) CXCR3KCNH2ALDH1A1MAPTHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed